Submission Details
| 510(k) Number | K251325 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 29, 2025 |
| Decision Date | May 29, 2025 |
| Days to Decision | 30 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K251325 is an FDA 510(k) clearance for the VersaCross Connect? Transseptal Dilator, a Dilator, Vessel, For Percutaneous Catheterization (Class II — Special Controls, product code DRE), submitted by Baylis Medical Company, Inc. (Mississauga, CA). The FDA issued a Cleared decision on May 29, 2025, 30 days after receiving the submission on April 29, 2025. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1310.
| 510(k) Number | K251325 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 29, 2025 |
| Decision Date | May 29, 2025 |
| Days to Decision | 30 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DRE — Dilator, Vessel, For Percutaneous Catheterization |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1310 |